HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway.

AbstractPURPOSE:
The authors examined whether olprinone, a phosphodiesterase type 3 inhibitor, or isoflurane, a volatile anesthetic, could protect the heart against myocardial infarction in type 2 diabetic rats and whether the underlying mechanisms involve protein kinase C (PKC), mitochondrial ATP-sensitive potassium (m-K(ATP)) channels, or the phosphatidylinositol 3-kinase (PI3K)-Akt pathway.
METHODS:
All rats underwent 30 min of coronary artery occlusion followed by 2 h of reperfusion. Wistar rats received isoflurane or olprinone before ischemia with or without the PKC inhibitor chelerythrine (CHE), the m-K(ATP) channel blocker 5-hydroxydecanoic acid (5HD), or the PI3K-Akt inhibitor LY294002 (LY). Goto-Kakizaki (GK) rats were randomly assigned to receive isoflurane or olprinone. In another group, GK rats received LY before the olprinone.
RESULTS:
In the Wistar rats, both isoflurane (38 +/- 11%) and olprinone (40 +/- 11%) reduced infarct size as compared to the control group (59 +/- 8%). In the GK rats, olprinone (41 +/- 9%) but not isoflurane (53 +/- 11%) reduced infarct size as compared to the GK control group (58 +/- 14%). The beneficial effects of olprinone were blocked by LY (58 +/- 14%). In the Wistar rats, CHE, 5HD, and LY prevented isoflurane-induced reductions of infarct size. On the other hand, LY but not CHE or 5HD prevented olprinone-induced reductions of infarct size.
CONCLUSIONS:
Olprinone but not isoflurane protects the heart against myocardial infarction in type 2 diabetic rats. The olprinone-induced cardioprotective effect is mediated by the PI3K-Akt pathway but not PKC or m-K(ATP) channels.
AuthorsShuhei Matsumoto, Sungsam Cho, Shinya Tosaka, Hiroyuki Ureshino, Takuji Maekawa, Tetsuya Hara, Koji Sumikawa
JournalCardiovascular drugs and therapy (Cardiovasc Drugs Ther) Vol. 23 Issue 4 Pg. 263-70 (Aug 2009) ISSN: 1573-7241 [Electronic] United States
PMID19597978 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anesthetics, Inhalation
  • Imidazoles
  • Phosphodiesterase Inhibitors
  • Potassium Channels
  • Pyridones
  • mitochondrial K(ATP) channel
  • olprinone
  • Isoflurane
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Protein Kinase C
Topics
  • Anesthetics, Inhalation (pharmacology)
  • Animals
  • Diabetes Mellitus, Experimental (complications)
  • Diabetes Mellitus, Type 2 (complications)
  • Imidazoles (pharmacology)
  • Isoflurane (pharmacology)
  • Male
  • Myocardial Infarction (prevention & control)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphodiesterase Inhibitors (pharmacology)
  • Potassium Channels (metabolism)
  • Protein Kinase C (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Pyridones (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Inbred Strains
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: